Wolverine Asset Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Wolverine Asset Management’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$498	Hold	54,752	–	–	﹤0.01%	1617
2025 Q4	$438	Hold	54,752	–	–	﹤0.01%	1598
2025 Q3	$684	Hold	54,752	–	–	﹤0.01%	1525
2025 Q2	$657	Hold	54,752	–	–	﹤0.01%	1527
2025 Q1	$591	Hold	54,752	–	–	﹤0.01%	1477
2024 Q4	$383	Buy	54,752 +32,550	+147%	+$381	﹤0.01%	1553
2024 Q3	$333	Sell	22,202 -50,000	-69%	-$700	﹤0.01%	1579
2024 Q2	$1.44K	Hold	72,202	–	–	﹤0.01%	1518
2024 Q1	$1.91K	Hold	72,202	–	–	﹤0.01%	1473
2023 Q4	$765	Hold	72,202	–	–	﹤0.01%	1631
2023 Q3	$1.22K	Sell	72,202 -1,805	-2%	-$30	﹤0.01%	1688
2023 Q2	$1.32K	Hold	74,007	–	–	﹤0.01%	1617
2023 Q1	$1.2K	Hold	74,007	–	–	﹤0.01%	1694
2022 Q4	$969	Buy	74,007 +6,734	+10%	+$214	﹤0.01%	1944
2022 Q3	$2K	Hold	67,273	–	–	﹤0.01%	2255
2022 Q2	$5K	Buy	67,273 +1,000	+2%	+$84	﹤0.01%	2125
2022 Q1	$8K	Buy	+66,273	New	+$16.9K	﹤0.01%	1947

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

QWM

Quaker Wealth Management Moorestown, New Jersey $320M AUM 13.7% 1-Year Est. Return

Wolverine Asset Management's REVBW Position: Q1 2026 in Review

Wolverine Asset Management held its Revelation Biosciences Warrant (REVBW) position steady in Q1 2026 at 54,752 shares worth $498. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Wolverine Asset Management first reported a position in REVBW in Q1 2022 and has held it in 17 quarters since. The position peaked at $8K in Q1 2022. 11 funds tracked by Wall St. Rank hold REVBW as of Q1 2026.

Wolverine Asset Management held 54,752 shares of Revelation Biosciences Warrant worth $498 as of Q1 2026.
Wolverine Asset Management left its Revelation Biosciences Warrant share count unchanged in Q1 2026.
Revelation Biosciences Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1617 holding.
Wolverine Asset Management first reported a position in Revelation Biosciences Warrant in Q1 2022 and has held it in 17 quarters since.
Wolverine Asset Management's Revelation Biosciences Warrant position peaked at $8K in Q1 2022.
11 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.